Koers Otsuka Holdings Co., Ltd. Other OTC
Aandelen
OTSKY
US6891641010
Farmaceutische producten
Omzet 2024 * | 2.168 mld. 13,97 mld. 13,01 mld. | Omzet 2025 * | 2.153 mld. 13,87 mld. 12,91 mld. | Marktkapitalisatie | 3.507 mld. 22,6 mld. 21,04 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 254 mld. 1,64 mld. 1,53 mld. | Nettowinst (verlies) 2025 * | 233 mld. 1,5 mld. 1,4 mld. | EV/omzet 2024 * | 1,39 x |
Nettoliquiditeiten 2024 * | 496 mld. 3,2 mld. 2,98 mld. | Nettoliquiditeiten 2025 * | 635 mld. 4,09 mld. 3,81 mld. | EV/omzet 2025 * | 1,33 x |
K/w-verhouding 2024 * |
13,7
x | K/w-verhouding 2025 * |
14,7
x | Werknemers | - |
Dividendrendement 2024 * |
1,86% | Dividendrendement 2025 * |
1,93% | Vrij verhandelbaar | 81,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Tatsuo Higuchi
CEO | Chief Executive Officer | 73 | 08-07-08 |
Yuko Makino
DFI | Director of Finance/CFO | 62 | 01-03-15 |
Ichiro Otsuka
CHM | Chairman | 59 | 08-07-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tatsuo Higuchi
CEO | Chief Executive Officer | 73 | 08-07-08 |
Ichiro Otsuka
CHM | Chairman | 59 | 08-07-08 |
Director/Board Member | 57 | 30-03-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,32% | 43,95 mld. | |
+11,68% | 14,71 mld. | |
+11,31% | 13,77 mld. | |
+42,32% | 12,3 mld. | |
-9,02% | 7,03 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+12,33% | 5,48 mld. | |
-3,58% | 4,75 mld. |